NeuroPace (NPCE) Net Margin (2020 - 2026)

NeuroPace (NPCE) recorded quarterly Net Margin of 29.56% in Q1 2026, down 188.03% quarter-over-quarter from 10.26% in Q4 2025, and down 67.0% on a YoY basis from 89.59% in Q1 2025.

NeuroPace (NPCE) Net Margin (2020 - 2026) Analysis & Trends

NeuroPace's Net Margin history runs 7 years deep, the most recent figure standing at 29.56% for Q1 2026.

  • In Q1 2026, Net Margin fell 67.0% year-over-year to 29.56%; the TTM figure through Mar 2026 stood at 21.1% (up 853.0% YoY), while the FY2025 annual figure was 20.98%, up 1336.0% from the prior year.
  • Net Margin was 29.56% for Q1 2026 at NeuroPace, down from 10.26% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 10.26% in Q4 2025 to a low of 123.58% in Q2 2022.
  • Historically, Net Margin has averaged 51.44% across 5 years, with a median of 39.64% in 2024.
  • The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 7308 bps in 2022, then jumped 6758 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 86.01% in 2022, then jumped by 58 bps to 35.89% in 2023, then jumped by 33 bps to 24.06% in 2024, then jumped by 57 bps to 10.26% in 2025, then sank by 188 bps to 29.56% in 2026.
  • The last three Net Margin figures came in at 29.56% (Q1 2026), 10.26% (Q4 2025), and 13.08% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 NeuroPace 527.50 Mn 473.52 Mn 18.05 Mn -29.56%

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.56%
Dec 31, 2025 -10.26%
Sep 30, 2025 -13.08%
Jun 30, 2025 -34.72%
Mar 31, 2025 -28.89%
Dec 31, 2024 -24.06%
Sep 30, 2024 -26.93%
Jun 30, 2024 -39.64%
Mar 31, 2024 -49.53%
Dec 31, 2023 -35.89%
Sep 30, 2023 -44.88%
Jun 30, 2023 -56.00%
Mar 31, 2023 -66.04%
Dec 31, 2022 -86.01%
Sep 30, 2022 -104.71%
Jun 30, 2022 -123.58%
Mar 31, 2022 -100.74%
Dec 31, 2021 -97.22%
Sep 30, 2021 -76.73%
Jun 30, 2021 -50.50%